Peter Errhalt

535 total citations
33 papers, 324 citations indexed

About

Peter Errhalt is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Physiology. According to data from OpenAlex, Peter Errhalt has authored 33 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 7 papers in Physiology. Recurrent topics in Peter Errhalt's work include Lung Cancer Treatments and Mutations (10 papers), Pleural and Pulmonary Diseases (6 papers) and Lung Cancer Diagnosis and Treatment (6 papers). Peter Errhalt is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), Pleural and Pulmonary Diseases (6 papers) and Lung Cancer Diagnosis and Treatment (6 papers). Peter Errhalt collaborates with scholars based in Austria, United Kingdom and Russia. Peter Errhalt's co-authors include Klaus Hackner, Sabin Handzhiev, Annette Duck, Nazia Chaudhuri, Peter Schenk, Maximilian J. Hochmair, Martin Filipits, Bernhard Baumgartner, Ulrike Setinek and Anna Buder and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Peter Errhalt

32 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Errhalt Austria 11 212 84 60 57 41 33 324
Masaru Matsuoka Japan 9 192 0.9× 155 1.8× 77 1.3× 148 2.6× 69 1.7× 13 453
Catarina Sousa Portugal 8 121 0.6× 56 0.7× 79 1.3× 130 2.3× 8 0.2× 21 267
Jun Hyeok Lim South Korea 10 162 0.8× 88 1.0× 33 0.6× 51 0.9× 7 0.2× 42 297
Umberto Semenzato Italy 8 105 0.5× 21 0.3× 61 1.0× 133 2.3× 17 0.4× 27 249
L. Callol Spain 7 166 0.8× 223 2.7× 12 0.2× 49 0.9× 27 0.7× 22 576
Jamal Zaini Indonesia 10 66 0.3× 89 1.1× 30 0.5× 60 1.1× 12 0.3× 38 329
Jian‐Wei Huang China 10 102 0.5× 106 1.3× 72 1.2× 49 0.9× 21 0.5× 27 293
Shigeyuki Aoki Japan 11 207 1.0× 78 0.9× 30 0.5× 86 1.5× 13 0.3× 51 397
Hitoshi Yonezawa Japan 12 166 0.8× 135 1.6× 35 0.6× 96 1.7× 12 0.3× 24 379
Van K. Holden United States 11 186 0.9× 27 0.3× 36 0.6× 91 1.6× 11 0.3× 45 308

Countries citing papers authored by Peter Errhalt

Since Specialization
Citations

This map shows the geographic impact of Peter Errhalt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Errhalt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Errhalt more than expected).

Fields of papers citing papers by Peter Errhalt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Errhalt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Errhalt. The network helps show where Peter Errhalt may publish in the future.

Co-authorship network of co-authors of Peter Errhalt

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Errhalt. A scholar is included among the top collaborators of Peter Errhalt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Errhalt. Peter Errhalt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Neuditschko, Benjamin, Klaus Hackner, Franz Herzog, et al.. (2024). Favorable impact of PD1/PD-L1 antagonists on bone remodeling: an exploratory prospective clinical study and ex vivo validation. Journal for ImmunoTherapy of Cancer. 12(5). e008669–e008669. 6 indexed citations
2.
Guillien, Alicia, Katarzyna Niespodziana, Anne Boudier, et al.. (2024). Association between asthma and IgG levels specific for rhinovirus and respiratory syncytial virus antigens in children and adults. Journal of Allergy and Clinical Immunology Global. 4(1). 100342–100342. 1 indexed citations
3.
Guillien, Alicia, Katarzyna Niespodziana, Anne Boudier, et al.. (2024). Determinants of immunoglobulin G responses to respiratory syncytial virus and rhinovirus in children and adults. Frontiers in Immunology. 15. 1355214–1355214. 1 indexed citations
4.
Hackner, Klaus, et al.. (2022). Transbronchial lung cryobiopsy: prospective safety evaluation and 90-day mortality after a standardized examination protocol. Therapeutic Advances in Respiratory Disease. 16. 2673656890–2673656890. 2 indexed citations
5.
Sallard, Erwan, Katarzyna Niespodziana, Thomas Schlederer, et al.. (2022). Microarray-Based Analyses of Rhinovirus Species-Specific Antibody Responses in Exacerbated Pediatric Asthma in a German Pediatric Cohort. Viruses. 14(9). 1857–1857. 2 indexed citations
6.
Niespodziana, Katarzyna, et al.. (2022). Identification of Epitopes on Rhinovirus 89 Capsid Proteins Capable of Inducing Neutralizing Antibodies. International Journal of Molecular Sciences. 23(9). 5113–5113. 1 indexed citations
7.
Niespodziana, Katarzyna, et al.. (2022). Cumulative IgE-levels specific for respiratory allergens as biomarker to predict efficacy of anti-IgE-based treatment of severe asthma. Frontiers in Immunology. 13. 941492–941492. 6 indexed citations
8.
Niespodziana, Katarzyna, Nikolaos G. Papadopoulos, Margarete Focke‐Tejkl, et al.. (2021). Microarray Technology May Reveal the Contribution of Allergen Exposure and Rhinovirus Infections as Possible Triggers for Acute Wheezing Attacks in Preschool Children. Viruses. 13(5). 915–915. 9 indexed citations
9.
Base, Eva, Herbert Koinig, Klaus Hackner, et al.. (2020). Infraglottic versus supraglottic jet-ventilation for endobronchial ultrasound-guided transbronchial needle aspiration. European Journal of Anaesthesiology. 37(11). 999–1007. 4 indexed citations
10.
Ghanim, Bahil, Paul Stockhammer, Ali Çelik, et al.. (2020). Tumour cell PD-L1 expression is prognostic in patients with malignant pleural effusion: the impact of C-reactive protein and immune-checkpoint inhibition. Scientific Reports. 10(1). 5784–5784. 15 indexed citations
11.
Buder, Anna, Maximilian J. Hochmair, Sophia Schwab, et al.. (2018). Cell-Free Plasma DNA-Guided Treatment With Osimertinib in Patients With Advanced EGFR-Mutated NSCLC. Journal of Thoracic Oncology. 13(6). 821–830. 50 indexed citations
12.
Hochmair, Maximilian J., Martin Filipits, Andrea Mohn-Staudner, et al.. (2017). P3.02b-101 EGFR T790M Resistance Mutation in NSCLC: Real-Life Data of Austrian Patients Treated with Osimertinib. Journal of Thoracic Oncology. 12(1). S1254–S1254. 2 indexed citations
13.
Buder, Anna, Maximilian J. Hochmair, Andrea Mohn-Staudner, et al.. (2017). P3.02b-032 Association between EGFR T790M Mutation Copy Numbers in Cell-Free Plasma DNA and Response to Osimertinib in Advanced NSCLC. Journal of Thoracic Oncology. 12(1). S1205–S1206. 2 indexed citations
14.
Hackner, Klaus, et al.. (2017). Fever after bronchoscopy: serum procalcitonin enables early diagnosis of post-interventional bacterial infection. BMC Pulmonary Medicine. 17(1). 156–156. 7 indexed citations
15.
Hoda, Mir Alireza, Thomas Klikovits, Karin Dieckmann, et al.. (2016). Management of malignant pleural mesothelioma—part 2: therapeutic approaches. Wiener klinische Wochenschrift. 128(17-18). 618–626. 5 indexed citations
16.
Klikovits, Thomas, Mir Alireza Hoda, Bernhard Baumgartner, et al.. (2016). Management of malignant pleural mesothelioma – part 3. Wiener klinische Wochenschrift. 128(17-18). 627–634. 4 indexed citations
17.
Hackner, Klaus, Peter Errhalt, Michael Rolf Mueller, et al.. (2016). Canine scent detection for the diagnosis of lung cancer in a screening-like situation. Journal of Breath Research. 10(4). 46003–46003. 32 indexed citations
18.
Duck, Annette, et al.. (2015). IPF Care: A Support Program for Patients with Idiopathic Pulmonary Fibrosis Treated with Pirfenidone in Europe. Advances in Therapy. 32(2). 87–107. 36 indexed citations
19.
Errhalt, Peter, et al.. (2011). The Veres Adapter. Anesthesia & Analgesia. 112(3). 597–600. 9 indexed citations
20.
Steiner, Ilka, Peter Errhalt, Marion Holy, et al.. (2008). Pulmonary pharmacokinetics and safety of nebulized duramycin in healthy male volunteers. Naunyn-Schmiedeberg s Archives of Pharmacology. 378(3). 323–333. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masaru Matsuoka Breakdown of academic impact, for papers by Catarina Sousa Breakdown of academic impact, for papers by Jun Hyeok Lim Breakdown of academic impact, for papers by Umberto Semenzato Breakdown of academic impact, for papers by L. Callol Breakdown of academic impact, for papers by Jamal Zaini Breakdown of academic impact, for papers by Jian‐Wei Huang Breakdown of academic impact, for papers by Shigeyuki Aoki Breakdown of academic impact, for papers by Hitoshi Yonezawa Breakdown of academic impact, for papers by Van K. Holden
Rankless by CCL
2026